Mature T-Cell and NK-Cell Neoplasm — Trials

Mature T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

825 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 501–550 of 825 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02273739	Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation	completed	Phase 1 / Phase 2	21	CelgeneINDUSTRY	2	Feb 23, 2021	clinicaltrials
NCT04767308	Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies	unknown	Early Phase 1	18	Huazhong University of Science and TechnologyOTHER	0	Feb 23, 2021